Peking University Sixth Hospital/ Institute of Mental Health, Beijing, 100191, China.
NHC Key Laboratory of Mental Health (Peking University), National Clinical Research Center for Mental Disorders (Peking University Sixth Hospital), Beijing, 100191, China.
BMC Psychiatry. 2024 Mar 16;24(1):207. doi: 10.1186/s12888-024-05673-8.
The long-term effectiveness of cognitive behavioural therapy (CBT) in medicated attention-deficit/hyperactivity disorder (ADHD) adults with residual symptoms needs to be verified across multiple dimensions, especially with respect to maladaptive cognitions and psychological quality of life (QoL). An exploration of the mechanisms underlying the additive benefits of CBT on QoL in clinical samples may be helpful for a better understanding of the CBT conceptual model and how CBT works in medicated ADHD.
We conducted a secondary analysis of a randomised controlled trial including 98 medicated ADHD adults with residual symptoms who were randomly allocated to the CBT combined with medication (CBT + M) group or the medication (M)-only group. Outcomes included ADHD-core symptoms (ADHD Rating Scale), depression symptoms (Self-rating Depression Scale), maladaptive cognitions (Automatic Thoughts Questionnaire and Dysfunctional Attitude Scale), and psychological QoL (World Health Organization Quality of Life-Brief Version-psychological domain). Mixed linear models (MLMs) were used to analyse the long-term effectiveness at one-year follow-up, and structural equation modeling (SEM) was performed to explore the potential mechanisms of CBT on psychological QoL.
ADHD patients in the CBT + M group outperformed the M-only group in reduction of ADHD core symptoms (d = 0.491), depression symptoms (d = 0.570), a trend of reduction of maladaptive cognitions (d = 0.387 and 0.395, respectively), and improvement of psychological QoL (d = - 0.433). The changes in above dimensions correlated with each other (r = 0.201 ~ 0.636). The influence of CBT on QoL was mediated through the following four pathways: 1) changes in ADHD core symptoms; 2) changes in depressive symptoms; 3) changes in depressive symptoms and then maladaptive cognitions; and 4) changes firstly in depressive symptoms, maladaptive cognitions, and then ADHD core symptoms.
The long-term effectiveness of CBT in medicated ADHD adults with residual symptoms was further confirmed. The CBT conceptual model was verified in clinical samples, which would be helpful for a deeper understanding of how CBT works for a better psychological QoL outcome.
ChiCTR1900021705 (2019-03-05).
需要从多个维度验证认知行为疗法(CBT)在有残留症状的药物治疗注意力缺陷/多动障碍(ADHD)成年患者中的长期疗效,尤其是在适应不良认知和心理生活质量(QoL)方面。探索 CBT 对临床样本中 QoL 的附加益处的潜在机制,可能有助于更好地理解 CBT 概念模型以及 CBT 在药物治疗 ADHD 中的作用方式。
我们对一项随机对照试验进行了二次分析,该试验纳入了 98 例有残留症状的药物治疗 ADHD 成人患者,他们被随机分配至 CBT 联合药物(CBT+M)组或单纯药物(M)组。结局包括 ADHD 核心症状(ADHD 评定量表)、抑郁症状(自评抑郁量表)、适应不良认知(自动思维问卷和功能失调态度量表)和心理 QoL(世界卫生组织生活质量简明量表-心理领域)。采用混合线性模型(MLMs)分析一年随访时的长期疗效,采用结构方程模型(SEM)探索 CBT 对心理 QoL 的潜在机制。
CBT+M 组的 ADHD 患者在 ADHD 核心症状(d=0.491)、抑郁症状(d=0.570)、适应不良认知(分别为 d=0.387 和 0.395,呈下降趋势)和心理 QoL(d=-0.433)改善方面优于 M 组。各维度的变化相互关联(r=0.201~0.636)。CBT 对 QoL 的影响通过以下四条途径产生:1)ADHD 核心症状的变化;2)抑郁症状的变化;3)抑郁症状和适应不良认知的变化;4)抑郁症状、适应不良认知和 ADHD 核心症状的首先变化。
进一步证实了 CBT 对有残留症状的药物治疗 ADHD 成年患者的长期疗效。该研究在临床样本中验证了 CBT 概念模型,有助于更深入地了解 CBT 如何改善心理 QoL。
ChiCTR1900021705(2019-03-05)。